Yahoo
NasdaqGM - Nasdaq Real Time Price USD

biote Corp. (BTMD)

1.0500 +0.0100 (+0.96%)
As of 11:25:15 AM EST. Market Open.
BTMD Q3 2026 earnings call
Replay the call for the latest insights.
Read transcript

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Marc D. Beer
Executive Chairman 459.06k -- 1965
Mr. Robert C. Peterson
Interim CEO, CFO & Chief Business Officer 675.61k -- 1977
Mr. John J. Olsen
Chief Information Officer -- -- 1957
Mr. Dan Monico
General Counsel -- -- --
Mr. Richard Kevin Key
Chief Digital Officer -- -- 1971
Mr. Jade Beutler
Head of Nutraceuticals -- -- 1964
Dr. Cory Rice D.O.
Chief Clinical Advisor & Member of Medical Advisory Board -- -- --
Mr. Joey Lopes
SVP of Strategy & Commercial Operations -- -- --
Dr. Komal Bajaj M.D., M.S.
Chief Medical Officer -- -- --

biote Corp.

1875 W. Walnut Hill Ln #100
Irving, TX 75038
United States
844 604 1246 https://www.biote.com
Sector: 
Healthcare
Full Time Employees: 
223

Description

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Corporate Governance

biote Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 4, 2026 at 9:00 PM UTC

biote Corp. Earnings Date

Recent Events

November 4, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 7, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 17, 2026 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

June 2, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 18, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 11, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 14, 2026 at 12:00 AM UTC

S-8: Offering Registrations

April 3, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: